Fox Chase Cancer Center Fox Chase Cancer (2) — Philadelphia, Pennsylvania

Fox Chase Cancer Center Fox Chase Cancer (2) is a clinical research site located in Philadelphia, Pennsylvania, United States 19111.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Fox Chase Cancer Center Fox Chase Cancer (2) has participated in 2 clinical trials.

Therapeutic areas: Tumors Characterized by Genetic Abnormalities of ALK, Anaplastic Lymphoma Kinase (ALK), Non-small Cell Lung Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fox Chase Cancer Center Fox Chase Cancer (2)?

Fox Chase Cancer Center Fox Chase Cancer (2) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fox Chase Cancer Center Fox Chase Cancer (2) conducted?

Fox Chase Cancer Center Fox Chase Cancer (2) has 2 clinical trials on record. Their work covers Tumors Characterized by Genetic Abnormalities of ALK, Anaplastic Lymphoma Kinase (ALK), Non-small Cell Lung Cancer.

Is Fox Chase Cancer Center Fox Chase Cancer (2) accredited by Crixeo Health?

Fox Chase Cancer Center Fox Chase Cancer (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fox Chase Cancer Center Fox Chase Cancer (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.